{"ticker": {"uuid": "1224bcae-3e75-421c-ab64-18db89386926", "symbol": "AMIX", "name": "Autonomix Medical, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants", "summary": "Autonomix Medical (AMIX) has secured approximately $2.6 million in gross proceeds through a warrant inducement letter. The company reduced the exercise price of existing Series C warrants to $6.00 and issued new Series D-1 and D-2 warrants for 428,731 shares each, with an exercis", "url": "https://www.tradingview.com/news/tradingview:7f7d54816f7e9:0-autonomix-medical-secures-2-6-million-from-warrant-inducement-issues-new-series-d-warrants/", "source_name": "TradingView", "published_at": "2026-07-15T21:13:24", "published_display": "15 Jul 2026 21:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical receives patent for overactive bladder device", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQenU0UnBuRWFaVWlkbkpNbS1rTzBmMEFtYU5vSVhWMkF6Q2JfUmlxWnBoV1dpTHFTY250SVQwb09HQ3JJMmNDQURfZU1GX3ZZazRFbVUzWWk1MkFvUXVlQl9oVUNXNWlWVG9WV3dWUXVncXdVcGNuLTU1SExETGlzWE9NbjRFSDlvNUx1Nzl0bHlBQ3NzaHdFYURJeGdWQlpmUVRhR0ZlTTFORk5nM3RheGtXblMxTGNOc2FLSjBSYnJxbUNEbGxjbnB3TTVtQmJJMUE?oc=5", "source_name": "Investing.com UK", "published_at": "2026-07-15T18:12:52+00:00", "published_display": "15 Jul 2026 18:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical receives patent for overactive bladder device By Investing.com", "summary": "Autonomix Medical Inc. (NASDAQ:AMIX) has been granted a patent for a catheter-based system to diagnose and treat overactive bladder, expanding its platform technology into a significant clinical market. Despite the company's stock experiencing a significant drop, InvestingPro ana", "url": "https://ng.investing.com/news/stock-market-news/autonomix-medical-receives-patent-for-overactive-bladder-device-93CH-2600834", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T14:13:24", "published_display": "15 Jul 2026 14:13", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Receives US Patent Covering Neural Sensing Technology for Overactive Bladder", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/autonomix-medical-receives-us-patent-124059367.html", "source_name": "MT Newswires", "published_at": "2026-07-15T12:40:59+00:00", "published_display": "15 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform", "summary": "Autonomix Medical, Inc. announced it has been granted a U.S. patent for a new platform designed for the diagnosis and treatment of overactive bladder (OAB), a condition affecting approximately 37 million Americans. The patented system uses a catheter-based approach for minimally ", "url": "https://www.globenewswire.com/news-release/2026/07/15/3327649/0/en/autonomix-medical-granted-u-s-patent-for-overactive-bladder-diagnosis-and-treatment-platform.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T13:11:27", "published_display": "15 Jul 2026 13:11", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Patent Covers Catheter That Maps and Treats Bladder Nerves", "summary": "Autonomix Medical (NASDAQ: AMIX) has been granted a U.S. patent for a platform designed to diagnose and treat overactive bladder (OAB), expanding its neural sensing and therapeutic technology into urology. The patent covers a catheter-based system for nerve mapping and targeted t", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-granted-u-s-patent-for-overactive-bladder-yw7l2576u0m0.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:59:35", "published_display": "15 Jul 2026 11:59", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Autonomix Medical raises up to $2.6M through warrant inducement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPYmd2RzhxVWpNdURhNllRZXRIWW14RGVvaEVIeXJvaC1vM0J4LWR0VW45RFNIYmNYRXp0TW8zdE9CSUQ3YkhSNVAzT2c0NjZsd3JyazBUWnBqWFcwS0l5RS1aZDcydmhTdGx4YS1samt6SEUyTWlqM2hTZ21oUDNXcEZMd1U3Qjk4ZG5DQUptQlVPUUJJVXNkWUdYRDBtVzJMUXlpcTM5RElCY1ZoTWt1N1lSZXRUa2s?oc=5", "source_name": "MSN", "published_at": "2026-07-14T10:03:32+00:00", "published_display": "14 Jul 2026 10:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules", "summary": "Autonomix Medical, Inc. announced a warrant inducement agreement resulting in an immediate exercise of outstanding warrants from November 2025. This agreement is expected to generate approximately $2.6 million in gross proceeds and involves the issuance of new unregistered Series", "url": "https://www.globenewswire.com/news-release/2026/07/14/3326547/0/en/autonomix-medical-enters-into-2-6-million-warrant-inducement-priced-at-the-market-under-nasdaq-rules.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T01:42:16", "published_display": "14 Jul 2026 01:42", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor Agrees to Exercise 428,731 Autonomix Warrants", "summary": "Autonomix Medical (NASDAQ: AMIX) has entered into a warrant inducement agreement with an existing investor for the immediate cash exercise of 428,731 outstanding warrants at an amended exercise price of $6.00 per share, expected to generate approximately $2.6 million in gross pro", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-enters-into-2-6-million-warrant-inducement-priced-bscyilf6bx2z.html", "source_name": "Stock Titan", "published_at": "2026-07-14T01:42:16", "published_display": "14 Jul 2026 01:42", "sentiment": "negative", "sentiment_pct": 39, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical, Inc. Common Stock (NASDAQ: AMIX) Share Price, AMIX Stock News, AMIX Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5LRGl1Q3IwdXVWaktiREVRYUVYR0pYTlVubS1oTng0a2hEOVVoWmxZVUR5Y1JYeHJOZ080Z25kZWlBcGU4TklWSHRLeTlmSDF4ZzAyaS1R?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T22:49:18+00:00", "published_display": "13 Jul 2026 22:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Receives Canadian Patent for Neural Sensing Technology", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/autonomix-medical-receives-canadian-patent-122747452.html", "source_name": "MT Newswires", "published_at": "2026-07-13T12:27:47+00:00", "published_display": "13 Jul 2026 12:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant", "summary": "Autonomix Medical has secured a new Canadian patent, \"Endoscopic Sympathectomy Systems and Methods,\" expanding its global intellectual property portfolio to 112 issued or pending patent applications. This patent enhances the company's position in neural sensing and precision nerv", "url": "https://sg.finance.yahoo.com/news/autonomix-medical-strengthens-global-intellectual-113000473.html", "source_name": "Market source", "published_at": "2026-07-13T12:42:16", "published_display": "13 Jul 2026 12:42", "sentiment": "positive", "sentiment_pct": 94, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical wins new patent for neural sensing technology", "summary": "Autonomix Medical Inc. (NASDAQ:AMIX) has secured a new patent for its neural sensing technology, enhancing its intellectual property in the denervation market. This patent reinforces the company's leadership in the multi-billion-dollar denervation market by legally protecting its", "url": "https://www.proactiveinvestors.com/companies/news/1095357/autonomix-medical-wins-new-patent-for-neural-sensing-technology-1095357.html", "source_name": "Proactive financial news", "published_at": "2026-07-13T12:40:36", "published_display": "13 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Canadian Patent Grant Strengthening Its Real-Time Nerve Sensing and Denervation IP Portfolio", "summary": "Autonomix Medical Inc. has been granted Canadian Patent No. 3,158,197, titled \"Endoscopic Sympathectomy Systems and Methods,\" expanding its global intellectual property portfolio to 112 patents. This new patent enhances its real-time nerve sensing, mapping, and neuromodulation te", "url": "https://www.quiverquant.com/news/Autonomix+Medical+Announces+Canadian+Patent+Grant+Strengthening+Its+Real-Time+Nerve+Sensing+and+Denervation+IP+Portfolio", "source_name": "Quiver Quantitative", "published_at": "2026-07-13T11:40:48", "published_display": "13 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Autonomix patent targets nerves behind hypertension and heart, kidney disease", "summary": "Autonomix Medical (NASDAQ: AMIX) has been granted Canadian Patent No. 3,158,197 for \"Endoscopic Sympathectomy Systems and Methods,\" enhancing its global intellectual property portfolio for nerve-targeted therapies. This patent strengthens the company's position in real-time nerve", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-strengthens-global-intellectual-property-position-gowtcs9ugfzw.html", "source_name": "Stock Titan", "published_at": "2026-07-13T11:39:48", "published_display": "13 Jul 2026 11:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status", "summary": "Autonomix Medical, Inc. (AMIX) has successfully regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. The company's stock maintained a closing price of $1.00 or higher for 10 consecutive business days, resolv", "url": "https://www.theglobeandmail.com/investing/markets/stocks/AMIX/pressreleases/3238482/autonomix-medical-regains-nasdaq-compliance-preserving-listing-status/", "source_name": "The Globe and Mail", "published_at": "2026-07-11T08:06:00", "published_display": "11 Jul 2026 08:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak", "summary": "Autonomix Medical (AMIX) has regained compliance with Nasdaq's $1.00 bid-price rule. This followed its stock closing at or above $1.00 for ten consecutive business days, from June 24 to July 8, 2026. The matter is now closed, confirming the company's compliance with Rule 5550(a)(", "url": "https://www.tradingview.com/news/tradingview:a799cb290c10e:0-autonomix-medical-regains-nasdaq-compliance-after-10-day-1-00-bid-price-streak/", "source_name": "TradingView", "published_at": "2026-07-10T12:39:11", "published_display": "10 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance", "summary": "Autonomix Medical (NASDAQ: AMIX) has regained compliance with Nasdaq's minimum bid price requirement for listing on the Nasdaq Capital Market. The company received a deficiency notice on January 14, 2026, after its common stock fell below $1.00 per share for 30 consecutive busine", "url": "https://www.stocktitan.net/sec-filings/AMIX/8-k-autonomix-medical-inc-reports-material-event-220bee6d66d6.html", "source_name": "Stock Titan", "published_at": "2026-07-10T12:39:11", "published_display": "10 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMIX - Autonomix Medical Inc Options", "summary": "This article provides a detailed financial overview of Autonomix Medical Inc. (AMIX), including its last close price, percentage change, market capitalization, key financial ratios, earnings per share data, and performance metrics over various periods. It also lists insider and i", "url": "https://finviz.com/stock?t=AMIX&ty=oc&p=w&b=1", "source_name": "Finviz", "published_at": "2026-07-04T09:42:01", "published_display": "04 Jul 2026 09:42", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMIX - Autonomix Medical Inc Latest SEC Filings", "summary": "This article provides detailed financial and stock performance data for Autonomix Medical Inc (AMIX) as of July 2, 2024. It covers key metrics such as market cap, income, sales, EPS, various ratios, insider ownership, and stock performance over different periods. The data indicat", "url": "https://finviz.com/stock?t=AMIX&ty=lf&p=w&b=1", "source_name": "Finviz", "published_at": "2026-07-03T21:40:51", "published_display": "03 Jul 2026 21:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Company Advances R&D - Book Value Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNVndxdUYxTjRXbDFEYXhseGdOQkk3VUE3UUZjalVCX0xSN0dnVmNkd3dmTmdhTlJaOWNtSzdtR1lqVFhsZTh2Rk4xQ0tpdnRMY05wX3BoRGtXSWZuaEIzUk9WNmlxRm53ZjJhSTBpbmpjbFpKOF93cnFMUlhzWENmVzYtMERJOG5lUDNtUEZVaFVPUEppVUJldEQwemxXY2RzVFA3MzJDaW92cHJ1UDZSeUdKOW9pN2dRMElEWFlfcGFPdzZ1SlBEemZadjFXT29ZMG8tb0lKcVl5MkUxMVE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Autonomix Medical, Inc. \u2013 NASDAQ:AMIX", "summary": "This article provides financial information for Autonomix Medical, Inc. (NASDAQ: AMIX), specifically focusing on its enterprise value to EBIT forward. It appears to be a financial data page from TradingView, displaying stock market information and company financial metrics.", "url": "https://www.tradingview.com/symbols/NASDAQ-AMIX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T09:42:01", "published_display": "28 Jun 2026 09:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Autonomix Medical, Inc. \u2013 NASDAQ:AMIX", "summary": "The article presents financial information for Autonomix Medical, Inc. (NASDAQ: AMIX), specifically focusing on its price to book forward. It is a brief entry from TradingView, displaying market status and financial data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-AMIX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T23:41:46", "published_display": "25 Jun 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (AMIX) consolidates shares in 1-for-21 reverse stock split", "summary": "Autonomix Medical (AMIX) has announced a 1-for-21 reverse stock split, effective June 24, 2026, which will reduce its outstanding common shares from approximately 11.4 million to 542,000. Each 21 shares will be combined into one, with fractional shares being compensated in cash, ", "url": "https://www.stocktitan.net/sec-filings/AMIX/8-k-autonomix-medical-inc-reports-material-event-9cbf4503a82c.html", "source_name": "Stock Titan", "published_at": "2026-06-24T11:09:57", "published_display": "24 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change", "summary": "Autonomix Medical has announced a standalone neural sensing program, building on preclinical results that demonstrated real-time detection of renal neural activity changes. This platform, which leverages the core sensing technology from their pancreatic cancer pain program, aims ", "url": "https://finance.yahoo.com/healthcare/articles/autonomix-medical-announces-standalone-neural-120000816.html", "source_name": "Market source", "published_at": "2026-06-22T12:12:13", "published_display": "22 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix sees real-time renal nerve activity changes in preclinical tests", "summary": "Autonomix Medical (NASDAQ: AMIX) has announced a proprietary standalone neural sensing platform, showcasing preclinical evidence of detecting real-time renal nerve activity and changes post-intervention. This platform, built on the company's core technology, initially targets ren", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-announces-standalone-neural-sensing-program-with-kdm15o7pdxo0.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:12:13", "published_display": "22 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Standalone Neural Sensing", "summary": "Autonomix Medical, Inc. announced the development of a proprietary standalone neural sensing platform, following preclinical results demonstrating its ability to identify renal neural activity and detect real-time changes post-intervention. This platform, built on the same core t", "url": "https://www.globenewswire.com/news-release/2026/06/22/3315242/0/en/autonomix-medical-announces-standalone-neural-sensing-program-with-evidence-of-real-time-renal-nerve-activity-change.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T08:00:00", "published_display": "22 Jun 2026 08:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Inc (AMIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Autonomix Medical Inc (AMIX), detailing its current support, resistance, indicators, and moving averages. According to the analysis, the stock exhibits multiple 'sell' signals across various technical indicators and moving averages, s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-amix/technical", "source_name": "TradingKey", "published_at": "2026-06-21T06:40:59", "published_display": "21 Jun 2026 06:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical announces 1-for-21 reverse stock split", "summary": "Autonomix Medical (AMIX) has announced a 1-for-21 reverse stock split set to take effect at the opening of trading on June 20, 2024. This action is primarily aimed at regaining compliance with Nasdaq's minimum bid price requirement. The company's Class A common stock will trade o", "url": "http://www.msn.com/en-us/money/topstocks/autonomix-medical-announces-1-for-21-reverse-stock-split/ar-AA25ZGcq?ocid=finance-verthp-feeds&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-19T16:10:25", "published_display": "19 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical to Effect 1-for-21 Reverse Stock Split June 24", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/autonomix-medical-effect-1-21-204958731.html", "source_name": "MT Newswires", "published_at": "2026-06-18T20:49:58+00:00", "published_display": "18 Jun 2026 20:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical announces 1-for-21 reverse stock split By Investing.com", "summary": "Autonomix Medical, Inc. (NASDAQ:AMIX) is implementing a 1-for-21 reverse stock split, effective June 24, 2026, to consolidate its common stock and maintain its Nasdaq listing. This action will reduce outstanding shares from approximately 11.4 million to 543,000, while the company", "url": "https://m.au.investing.com/news/stock-market-news/autonomix-medical-announces-1for21-reverse-stock-split-93CH-4495799?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-18T20:40:38", "published_display": "18 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Announces Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOdXNlWHlTelZWWTdRR1NfSDEtYnJ1QUkxNDkxdlB6SmlkejhXWmppdXJlUkU2VFdxQjU3VEZiV1hJek1TT0lLUlJqa1Y0ZzlDME5zcGlmM1VIRnRDWEdwTDhBdjlOMkRUc3laWjVkUkxiT2dlemlKeEhKT1Z1T1pianNDdG5PYUxlVDFadXJfNTYzSlBsdDdKel9fcjRIbkM5ZmpaRENFVlZSLWF6V1dSTA?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix\u2019s shares will be cut 21-for-1 on June 24", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRllFRjNNSFR6T2kxTU5xU0RSVm9ORXlsOE5UQ3Izd1M5WnJpSkMzdjdIZkIzS2lSVG9VNE8zdzJCRlp2WXRlYVV6aUkwb0NiWG91OURndkhfUy1OVXFTcjY1OXJOd2tBMDJSaWxRYURqRHB4enY0UzczMWpsdmRJVDlCQVRyNjMyQU9FZVBjcjJxZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor \"What This Means\" Segment Featuring City of Hope Chief of Medicine", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/autonomix-medical-highlights-clinical-data-130500364.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T13:05:00+00:00", "published_display": "04 Jun 2026 13:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/autonomix-medical-inc-granted-u-123000578.html", "source_name": "GlobeNewswire", "published_at": "2026-05-19T12:30:00+00:00", "published_display": "19 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Abstract Acceptances at EuroPCR", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxOaFBJWlJ6NXZxS0I4R2RoUUY1Wjh4alJMZTVBTXl5Q0EyYmRvdDk2LXp0c2xMT3lCZHpianVVTXVjVktnZ0k2OFBiVHlqdG1QbnAyRERKWlBPRVRyTXZoZlRqbGROUUktLW93bTBma0VHQ3FrUnZ1aU45X3ROQ1JSY0pNblE3NHREaURfbFBfYjJoMzFlMUF1V0FtcDdsOVYxMWVPRUhySFRYa0hWNGQ1V282dDlmb01LdU9zQ21GRXVyRWFDc3R1QnMwc3A0SXMxV2hBaW1zazRnOTY3MUQzaTB2c3ZfU0tGeFdjcnRGcXZnOUpMbE16ZTFnZkpQclU3VjkxTnBQd08xWmlmSDBjY2RYNG1uNG9oTzRINVdfYWdZdlFYTlE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How Is Zimmer Biomet Holdings\u2019 Stock Performance Compared to Other Medical Devices Stocks?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOS0lDWU0xdENCY2s5VjNmclpmZmpVb3RMNm5zbUpkUWt2S2RPdGpFU1B2RE9pS3J1eC1zSU5PRXprZkU2TUNVWHpVZTl5YWF5cVRqWUhJd2dLdGJEOXU5TEU4Z05zTmxWVmJwZU1IX0tuTm1MemwybnFEX3VWSzN1YVZYSVJMNW9qVTNPdk44WQ?oc=5", "source_name": "Market source", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Autonomix Medical, Inc. (AMIX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9fbkZDSktWdGVVMzdmQUVscjRhTXFKZUVVOTFsNjI3aWxKS0VBTXg2ajREUnVCZi16eEt0SlBxVi1mZlFCd0FfX2kyWEtfdE1Xek1yNXpZLXBuanRhc0JfQ0VxQ3cxcEdJQ0FoOA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (AMIX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1LUWJXMlJpMVExZlhHbXFSdXhJQzdJM1BEM295TXpZYkhOcl9XQklJai1HN25JQ2lScnRmcHJlaDJjd2lIYVJES0xlcWs2T1NRMEJR?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:33:40+00:00", "published_display": "24 Apr 2025 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxPa0pDbkFNTFpsWnowNV96c2VRT2tDRno2SFg4b0Vrb2cwUEZnaHFtMDE4dzBxaGxxclZxWGlDUnhGbDRBeHF0aUgtczBjNExMZjVZSkpTdlRPTUFpUzJmck1ZTndONmJ4d3F1QXNCMHZVbEdUT3VsaW5Ld0FDTk9PLW1DYUV1TW00Q1lZcmVJaTAtZnlvbXZ0djFQZGxPVmZqbURSVUpHWVpmcHFMVnRxSlZXTG90azZaTzQ3eV80R0d2bko0ekJwQ0NjajVWMTRKZWkzMWVOU09ad21uOVdvdTRqM1lKeFdLOGgtOUFhWkp5dkg5VGlrQWY0cU1IMmFnTXZr?oc=5", "source_name": "Kalkine", "published_at": "2025-03-14T07:00:00+00:00", "published_display": "14 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (AMIX) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBPZGhQMUVIZ2FfWHlQLW1QWVJJY2IxVFU1YS1VazBRRjh3M3FnX191UC05SUI5NkRtUUNKZTNORmFLN1lwdUt0S1ZQQ3hnQQ?oc=5", "source_name": "Stock Titan", "published_at": "2024-02-26T07:36:12+00:00", "published_display": "26 Feb 2024 07:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1xdkFldW5pWXVWUkxkOTMydG5DcVpjRnBTYjhjRWllTHg4Q0xESW9aZXlsTXBPNU9UWlE2aHNTQ3ZhWTZnR0dWQW8tVmtvb3cy?oc=5", "source_name": "CNN", "published_at": "2024-01-30T02:21:34+00:00", "published_display": "30 Jan 2024 02:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants", "summary": "Autonomix Medical (AMIX) has secured approximately $2.6 million in gross proceeds through a warrant inducement letter. The company reduced the exercise price of existing Series C warrants to $6.00 and issued new Series D-1 and D-2 warrants for 428,731 shares each, with an exercis", "url": "https://www.tradingview.com/news/tradingview:7f7d54816f7e9:0-autonomix-medical-secures-2-6-million-from-warrant-inducement-issues-new-series-d-warrants/", "source_name": "TradingView", "published_at": "2026-07-15T21:13:24", "published_display": "15 Jul 2026 21:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical receives patent for overactive bladder device", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQenU0UnBuRWFaVWlkbkpNbS1rTzBmMEFtYU5vSVhWMkF6Q2JfUmlxWnBoV1dpTHFTY250SVQwb09HQ3JJMmNDQURfZU1GX3ZZazRFbVUzWWk1MkFvUXVlQl9oVUNXNWlWVG9WV3dWUXVncXdVcGNuLTU1SExETGlzWE9NbjRFSDlvNUx1Nzl0bHlBQ3NzaHdFYURJeGdWQlpmUVRhR0ZlTTFORk5nM3RheGtXblMxTGNOc2FLSjBSYnJxbUNEbGxjbnB3TTVtQmJJMUE?oc=5", "source_name": "Investing.com UK", "published_at": "2026-07-15T18:12:52+00:00", "published_display": "15 Jul 2026 18:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical receives patent for overactive bladder device By Investing.com", "summary": "Autonomix Medical Inc. (NASDAQ:AMIX) has been granted a patent for a catheter-based system to diagnose and treat overactive bladder, expanding its platform technology into a significant clinical market. Despite the company's stock experiencing a significant drop, InvestingPro ana", "url": "https://ng.investing.com/news/stock-market-news/autonomix-medical-receives-patent-for-overactive-bladder-device-93CH-2600834", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T14:13:24", "published_display": "15 Jul 2026 14:13", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Receives US Patent Covering Neural Sensing Technology for Overactive Bladder", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/autonomix-medical-receives-us-patent-124059367.html", "source_name": "MT Newswires", "published_at": "2026-07-15T12:40:59+00:00", "published_display": "15 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform", "summary": "Autonomix Medical, Inc. announced it has been granted a U.S. patent for a new platform designed for the diagnosis and treatment of overactive bladder (OAB), a condition affecting approximately 37 million Americans. The patented system uses a catheter-based approach for minimally ", "url": "https://www.globenewswire.com/news-release/2026/07/15/3327649/0/en/autonomix-medical-granted-u-s-patent-for-overactive-bladder-diagnosis-and-treatment-platform.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T13:11:27", "published_display": "15 Jul 2026 13:11", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Patent Covers Catheter That Maps and Treats Bladder Nerves", "summary": "Autonomix Medical (NASDAQ: AMIX) has been granted a U.S. patent for a platform designed to diagnose and treat overactive bladder (OAB), expanding its neural sensing and therapeutic technology into urology. The patent covers a catheter-based system for nerve mapping and targeted t", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-granted-u-s-patent-for-overactive-bladder-yw7l2576u0m0.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:59:35", "published_display": "15 Jul 2026 11:59", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical raises up to $2.6M through warrant inducement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPYmd2RzhxVWpNdURhNllRZXRIWW14RGVvaEVIeXJvaC1vM0J4LWR0VW45RFNIYmNYRXp0TW8zdE9CSUQ3YkhSNVAzT2c0NjZsd3JyazBUWnBqWFcwS0l5RS1aZDcydmhTdGx4YS1samt6SEUyTWlqM2hTZ21oUDNXcEZMd1U3Qjk4ZG5DQUptQlVPUUJJVXNkWUdYRDBtVzJMUXlpcTM5RElCY1ZoTWt1N1lSZXRUa2s?oc=5", "source_name": "MSN", "published_at": "2026-07-14T10:03:32+00:00", "published_display": "14 Jul 2026 10:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules", "summary": "Autonomix Medical, Inc. announced a warrant inducement agreement resulting in an immediate exercise of outstanding warrants from November 2025. This agreement is expected to generate approximately $2.6 million in gross proceeds and involves the issuance of new unregistered Series", "url": "https://www.globenewswire.com/news-release/2026/07/14/3326547/0/en/autonomix-medical-enters-into-2-6-million-warrant-inducement-priced-at-the-market-under-nasdaq-rules.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T01:42:16", "published_display": "14 Jul 2026 01:42", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor Agrees to Exercise 428,731 Autonomix Warrants", "summary": "Autonomix Medical (NASDAQ: AMIX) has entered into a warrant inducement agreement with an existing investor for the immediate cash exercise of 428,731 outstanding warrants at an amended exercise price of $6.00 per share, expected to generate approximately $2.6 million in gross pro", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-enters-into-2-6-million-warrant-inducement-priced-bscyilf6bx2z.html", "source_name": "Stock Titan", "published_at": "2026-07-14T01:42:16", "published_display": "14 Jul 2026 01:42", "sentiment": "negative", "sentiment_pct": 39, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical, Inc. Common Stock (NASDAQ: AMIX) Share Price, AMIX Stock News, AMIX Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5LRGl1Q3IwdXVWaktiREVRYUVYR0pYTlVubS1oTng0a2hEOVVoWmxZVUR5Y1JYeHJOZ080Z25kZWlBcGU4TklWSHRLeTlmSDF4ZzAyaS1R?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T22:49:18+00:00", "published_display": "13 Jul 2026 22:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Receives Canadian Patent for Neural Sensing Technology", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/autonomix-medical-receives-canadian-patent-122747452.html", "source_name": "MT Newswires", "published_at": "2026-07-13T12:27:47+00:00", "published_display": "13 Jul 2026 12:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant", "summary": "Autonomix Medical has secured a new Canadian patent, \"Endoscopic Sympathectomy Systems and Methods,\" expanding its global intellectual property portfolio to 112 issued or pending patent applications. This patent enhances the company's position in neural sensing and precision nerv", "url": "https://sg.finance.yahoo.com/news/autonomix-medical-strengthens-global-intellectual-113000473.html", "source_name": "Market source", "published_at": "2026-07-13T12:42:16", "published_display": "13 Jul 2026 12:42", "sentiment": "positive", "sentiment_pct": 94, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical wins new patent for neural sensing technology", "summary": "Autonomix Medical Inc. (NASDAQ:AMIX) has secured a new patent for its neural sensing technology, enhancing its intellectual property in the denervation market. This patent reinforces the company's leadership in the multi-billion-dollar denervation market by legally protecting its", "url": "https://www.proactiveinvestors.com/companies/news/1095357/autonomix-medical-wins-new-patent-for-neural-sensing-technology-1095357.html", "source_name": "Proactive financial news", "published_at": "2026-07-13T12:40:36", "published_display": "13 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Canadian Patent Grant Strengthening Its Real-Time Nerve Sensing and Denervation IP Portfolio", "summary": "Autonomix Medical Inc. has been granted Canadian Patent No. 3,158,197, titled \"Endoscopic Sympathectomy Systems and Methods,\" expanding its global intellectual property portfolio to 112 patents. This new patent enhances its real-time nerve sensing, mapping, and neuromodulation te", "url": "https://www.quiverquant.com/news/Autonomix+Medical+Announces+Canadian+Patent+Grant+Strengthening+Its+Real-Time+Nerve+Sensing+and+Denervation+IP+Portfolio", "source_name": "Quiver Quantitative", "published_at": "2026-07-13T11:40:48", "published_display": "13 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Autonomix patent targets nerves behind hypertension and heart, kidney disease", "summary": "Autonomix Medical (NASDAQ: AMIX) has been granted Canadian Patent No. 3,158,197 for \"Endoscopic Sympathectomy Systems and Methods,\" enhancing its global intellectual property portfolio for nerve-targeted therapies. This patent strengthens the company's position in real-time nerve", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-strengthens-global-intellectual-property-position-gowtcs9ugfzw.html", "source_name": "Stock Titan", "published_at": "2026-07-13T11:39:48", "published_display": "13 Jul 2026 11:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status", "summary": "Autonomix Medical, Inc. (AMIX) has successfully regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. The company's stock maintained a closing price of $1.00 or higher for 10 consecutive business days, resolv", "url": "https://www.theglobeandmail.com/investing/markets/stocks/AMIX/pressreleases/3238482/autonomix-medical-regains-nasdaq-compliance-preserving-listing-status/", "source_name": "The Globe and Mail", "published_at": "2026-07-11T08:06:00", "published_display": "11 Jul 2026 08:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak", "summary": "Autonomix Medical (AMIX) has regained compliance with Nasdaq's $1.00 bid-price rule. This followed its stock closing at or above $1.00 for ten consecutive business days, from June 24 to July 8, 2026. The matter is now closed, confirming the company's compliance with Rule 5550(a)(", "url": "https://www.tradingview.com/news/tradingview:a799cb290c10e:0-autonomix-medical-regains-nasdaq-compliance-after-10-day-1-00-bid-price-streak/", "source_name": "TradingView", "published_at": "2026-07-10T12:39:11", "published_display": "10 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance", "summary": "Autonomix Medical (NASDAQ: AMIX) has regained compliance with Nasdaq's minimum bid price requirement for listing on the Nasdaq Capital Market. The company received a deficiency notice on January 14, 2026, after its common stock fell below $1.00 per share for 30 consecutive busine", "url": "https://www.stocktitan.net/sec-filings/AMIX/8-k-autonomix-medical-inc-reports-material-event-220bee6d66d6.html", "source_name": "Stock Titan", "published_at": "2026-07-10T12:39:11", "published_display": "10 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMIX - Autonomix Medical Inc Options", "summary": "This article provides a detailed financial overview of Autonomix Medical Inc. (AMIX), including its last close price, percentage change, market capitalization, key financial ratios, earnings per share data, and performance metrics over various periods. It also lists insider and i", "url": "https://finviz.com/stock?t=AMIX&ty=oc&p=w&b=1", "source_name": "Finviz", "published_at": "2026-07-04T09:42:01", "published_display": "04 Jul 2026 09:42", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMIX - Autonomix Medical Inc Latest SEC Filings", "summary": "This article provides detailed financial and stock performance data for Autonomix Medical Inc (AMIX) as of July 2, 2024. It covers key metrics such as market cap, income, sales, EPS, various ratios, insider ownership, and stock performance over different periods. The data indicat", "url": "https://finviz.com/stock?t=AMIX&ty=lf&p=w&b=1", "source_name": "Finviz", "published_at": "2026-07-03T21:40:51", "published_display": "03 Jul 2026 21:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Company Advances R&D - Book Value Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNVndxdUYxTjRXbDFEYXhseGdOQkk3VUE3UUZjalVCX0xSN0dnVmNkd3dmTmdhTlJaOWNtSzdtR1lqVFhsZTh2Rk4xQ0tpdnRMY05wX3BoRGtXSWZuaEIzUk9WNmlxRm53ZjJhSTBpbmpjbFpKOF93cnFMUlhzWENmVzYtMERJOG5lUDNtUEZVaFVPUEppVUJldEQwemxXY2RzVFA3MzJDaW92cHJ1UDZSeUdKOW9pN2dRMElEWFlfcGFPdzZ1SlBEemZadjFXT29ZMG8tb0lKcVl5MkUxMVE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Autonomix Medical, Inc. \u2013 NASDAQ:AMIX", "summary": "This article provides financial information for Autonomix Medical, Inc. (NASDAQ: AMIX), specifically focusing on its enterprise value to EBIT forward. It appears to be a financial data page from TradingView, displaying stock market information and company financial metrics.", "url": "https://www.tradingview.com/symbols/NASDAQ-AMIX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T09:42:01", "published_display": "28 Jun 2026 09:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Autonomix Medical, Inc. \u2013 NASDAQ:AMIX", "summary": "The article presents financial information for Autonomix Medical, Inc. (NASDAQ: AMIX), specifically focusing on its price to book forward. It is a brief entry from TradingView, displaying market status and financial data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-AMIX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T23:41:46", "published_display": "25 Jun 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (AMIX) consolidates shares in 1-for-21 reverse stock split", "summary": "Autonomix Medical (AMIX) has announced a 1-for-21 reverse stock split, effective June 24, 2026, which will reduce its outstanding common shares from approximately 11.4 million to 542,000. Each 21 shares will be combined into one, with fractional shares being compensated in cash, ", "url": "https://www.stocktitan.net/sec-filings/AMIX/8-k-autonomix-medical-inc-reports-material-event-9cbf4503a82c.html", "source_name": "Stock Titan", "published_at": "2026-06-24T11:09:57", "published_display": "24 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change", "summary": "Autonomix Medical has announced a standalone neural sensing program, building on preclinical results that demonstrated real-time detection of renal neural activity changes. This platform, which leverages the core sensing technology from their pancreatic cancer pain program, aims ", "url": "https://finance.yahoo.com/healthcare/articles/autonomix-medical-announces-standalone-neural-120000816.html", "source_name": "Market source", "published_at": "2026-06-22T12:12:13", "published_display": "22 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix sees real-time renal nerve activity changes in preclinical tests", "summary": "Autonomix Medical (NASDAQ: AMIX) has announced a proprietary standalone neural sensing platform, showcasing preclinical evidence of detecting real-time renal nerve activity and changes post-intervention. This platform, built on the company's core technology, initially targets ren", "url": "https://www.stocktitan.net/news/AMIX/autonomix-medical-announces-standalone-neural-sensing-program-with-kdm15o7pdxo0.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:12:13", "published_display": "22 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Standalone Neural Sensing", "summary": "Autonomix Medical, Inc. announced the development of a proprietary standalone neural sensing platform, following preclinical results demonstrating its ability to identify renal neural activity and detect real-time changes post-intervention. This platform, built on the same core t", "url": "https://www.globenewswire.com/news-release/2026/06/22/3315242/0/en/autonomix-medical-announces-standalone-neural-sensing-program-with-evidence-of-real-time-renal-nerve-activity-change.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T08:00:00", "published_display": "22 Jun 2026 08:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Inc (AMIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Autonomix Medical Inc (AMIX), detailing its current support, resistance, indicators, and moving averages. According to the analysis, the stock exhibits multiple 'sell' signals across various technical indicators and moving averages, s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-amix/technical", "source_name": "TradingKey", "published_at": "2026-06-21T06:40:59", "published_display": "21 Jun 2026 06:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical announces 1-for-21 reverse stock split", "summary": "Autonomix Medical (AMIX) has announced a 1-for-21 reverse stock split set to take effect at the opening of trading on June 20, 2024. This action is primarily aimed at regaining compliance with Nasdaq's minimum bid price requirement. The company's Class A common stock will trade o", "url": "http://www.msn.com/en-us/money/topstocks/autonomix-medical-announces-1-for-21-reverse-stock-split/ar-AA25ZGcq?ocid=finance-verthp-feeds&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-19T16:10:25", "published_display": "19 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical to Effect 1-for-21 Reverse Stock Split June 24", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/autonomix-medical-effect-1-21-204958731.html", "source_name": "MT Newswires", "published_at": "2026-06-18T20:49:58+00:00", "published_display": "18 Jun 2026 20:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical announces 1-for-21 reverse stock split By Investing.com", "summary": "Autonomix Medical, Inc. (NASDAQ:AMIX) is implementing a 1-for-21 reverse stock split, effective June 24, 2026, to consolidate its common stock and maintain its Nasdaq listing. This action will reduce outstanding shares from approximately 11.4 million to 543,000, while the company", "url": "https://m.au.investing.com/news/stock-market-news/autonomix-medical-announces-1for21-reverse-stock-split-93CH-4495799?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-18T20:40:38", "published_display": "18 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Announces Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOdXNlWHlTelZWWTdRR1NfSDEtYnJ1QUkxNDkxdlB6SmlkejhXWmppdXJlUkU2VFdxQjU3VEZiV1hJek1TT0lLUlJqa1Y0ZzlDME5zcGlmM1VIRnRDWEdwTDhBdjlOMkRUc3laWjVkUkxiT2dlemlKeEhKT1Z1T1pianNDdG5PYUxlVDFadXJfNTYzSlBsdDdKel9fcjRIbkM5ZmpaRENFVlZSLWF6V1dSTA?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix\u2019s shares will be cut 21-for-1 on June 24", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRllFRjNNSFR6T2kxTU5xU0RSVm9ORXlsOE5UQ3Izd1M5WnJpSkMzdjdIZkIzS2lSVG9VNE8zdzJCRlp2WXRlYVV6aUkwb0NiWG91OURndkhfUy1OVXFTcjY1OXJOd2tBMDJSaWxRYURqRHB4enY0UzczMWpsdmRJVDlCQVRyNjMyQU9FZVBjcjJxZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor \"What This Means\" Segment Featuring City of Hope Chief of Medicine", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/autonomix-medical-highlights-clinical-data-130500364.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T13:05:00+00:00", "published_display": "04 Jun 2026 13:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/autonomix-medical-inc-granted-u-123000578.html", "source_name": "GlobeNewswire", "published_at": "2026-05-19T12:30:00+00:00", "published_display": "19 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical Announces Abstract Acceptances at EuroPCR", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxOaFBJWlJ6NXZxS0I4R2RoUUY1Wjh4alJMZTVBTXl5Q0EyYmRvdDk2LXp0c2xMT3lCZHpianVVTXVjVktnZ0k2OFBiVHlqdG1QbnAyRERKWlBPRVRyTXZoZlRqbGROUUktLW93bTBma0VHQ3FrUnZ1aU45X3ROQ1JSY0pNblE3NHREaURfbFBfYjJoMzFlMUF1V0FtcDdsOVYxMWVPRUhySFRYa0hWNGQ1V282dDlmb01LdU9zQ21GRXVyRWFDc3R1QnMwc3A0SXMxV2hBaW1zazRnOTY3MUQzaTB2c3ZfU0tGeFdjcnRGcXZnOUpMbE16ZTFnZkpQclU3VjkxTnBQd08xWmlmSDBjY2RYNG1uNG9oTzRINVdfYWdZdlFYTlE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Is Zimmer Biomet Holdings\u2019 Stock Performance Compared to Other Medical Devices Stocks?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOS0lDWU0xdENCY2s5VjNmclpmZmpVb3RMNm5zbUpkUWt2S2RPdGpFU1B2RE9pS3J1eC1zSU5PRXprZkU2TUNVWHpVZTl5YWF5cVRqWUhJd2dLdGJEOXU5TEU4Z05zTmxWVmJwZU1IX0tuTm1MemwybnFEX3VWSzN1YVZYSVJMNW9qVTNPdk44WQ?oc=5", "source_name": "Market source", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Autonomix Medical, Inc. (AMIX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9fbkZDSktWdGVVMzdmQUVscjRhTXFKZUVVOTFsNjI3aWxKS0VBTXg2ajREUnVCZi16eEt0SlBxVi1mZlFCd0FfX2kyWEtfdE1Xek1yNXpZLXBuanRhc0JfQ0VxQ3cxcEdJQ0FoOA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (AMIX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1LUWJXMlJpMVExZlhHbXFSdXhJQzdJM1BEM295TXpZYkhOcl9XQklJai1HN25JQ2lScnRmcHJlaDJjd2lIYVJES0xlcWs2T1NRMEJR?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:33:40+00:00", "published_display": "24 Apr 2025 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxPa0pDbkFNTFpsWnowNV96c2VRT2tDRno2SFg4b0Vrb2cwUEZnaHFtMDE4dzBxaGxxclZxWGlDUnhGbDRBeHF0aUgtczBjNExMZjVZSkpTdlRPTUFpUzJmck1ZTndONmJ4d3F1QXNCMHZVbEdUT3VsaW5Ld0FDTk9PLW1DYUV1TW00Q1lZcmVJaTAtZnlvbXZ0djFQZGxPVmZqbURSVUpHWVpmcHFMVnRxSlZXTG90azZaTzQ3eV80R0d2bko0ekJwQ0NjajVWMTRKZWkzMWVOU09ad21uOVdvdTRqM1lKeFdLOGgtOUFhWkp5dkg5VGlrQWY0cU1IMmFnTXZr?oc=5", "source_name": "Kalkine", "published_at": "2025-03-14T07:00:00+00:00", "published_display": "14 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Autonomix Medical (AMIX) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBPZGhQMUVIZ2FfWHlQLW1QWVJJY2IxVFU1YS1VazBRRjh3M3FnX191UC05SUI5NkRtUUNKZTNORmFLN1lwdUt0S1ZQQ3hnQQ?oc=5", "source_name": "Stock Titan", "published_at": "2024-02-26T07:36:12+00:00", "published_display": "26 Feb 2024 07:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1xdkFldW5pWXVWUkxkOTMydG5DcVpjRnBTYjhjRWllTHg4Q0xESW9aZXlsTXBPNU9UWlE2aHNTQ3ZhWTZnR0dWQW8tVmtvb3cy?oc=5", "source_name": "CNN", "published_at": "2024-01-30T02:21:34+00:00", "published_display": "30 Jan 2024 02:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 81, "total_relevant": 59, "sentiment_summary": {"positive": 17, "negative": 6, "neutral": 36, "score": 56, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 20.5, "count": 36}, {"event": "earnings", "label": "Earnings", "weight": 10.19, "count": 20}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 6.57, "latest_week": "2026-07-10", "one_week_move": 2.2, "four_week_move": -18.9, "twelve_week_move": -22.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.743806, "market_dynamics_buy_signal": false, "relative_strength": -62.585044, "fair_value_gap": -97.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 33.6786, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.2% over one week, -18.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Stock Titan", "count": 9}, {"label": "GlobeNewswire", "count": 7}, {"label": "TradingView", "count": 4}, {"label": "MT Newswires", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "MSN", "count": 2}, {"label": "Kalkine", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 48}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 36}, {"label": "Earnings", "count": 20}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "48", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.2% over one week, -18.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants"}], "updated_at": "2026-07-17T13:48:03.822377+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}